It's been too quiet these last two weeks. They put all the people into the psychiatrist specialty spots( which was a horrible process btw), and there's no instruction for how the rest of us should handle our psychiatry accounts moving forward. What are they going to do with all the vacant territories? There's just not enough in our bags now for all the people in the footprint. I'm anticipating somethings going to happen just after they announce the cresset winners
-
Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page
Too quiet- realignment or layoffs coming?
- Thread starter TSBTSIHTF
- Start date
-
- Tags
- None
<
You are contradicting yourself.. With all the vacant territories created, there won't be a layoff... With only Pysch's being taken out, there is even more work for the primary care side, not less.
Re-allignment maybe...
But I would only be worry about a layoff if we were losing products.. as it stand, all products will remain in our portfolio, and all the vacant territories will be absorbed into current ones
Realignment, and I agree we do not need the current head count in primary care. If you are currently a 2 person footprint you are most likely ok. If more than 2 I believe people with be realigned and some will end up unemployed. Not a "mass layoff" but enough to lay off some.
Yep, that sounds about right. 3 or more people in a footprint? I'd be nervous.
Two people carrying 6 products would be disastrous if Takeda's goal is to remain relevant and grow market share...
From what I am hearing the more likely scenario remains those area who lost a rep will be merged with existing footprints, while areas who did not get a speciality rep will remain largely unchanged...
Nothing grand, just small tweaks to geography... Am told no layoff will occur in any capacity
From what I am hearing the more likely scenario remains those area who lost a rep will be merged with existing footprints, while areas who did not get a speciality rep will remain largely unchanged...
Nothing grand, just small tweaks to geography... Am told no layoff will occur in any capacity
clearly none of you have heard the news...big league growth coming! 10 reps per footprint everything is going well. Believe me.
Reading this post is like watching comedy central...good for shits and giggles
There is no need for a layoff when people are getting forced out through PIP even though they are at or above goal lol 
Oh, ode to the corporate cost cutting measures...
Oh, ode to the corporate cost cutting measures...There is no need for a layoff when people are getting forced out through PIP even though they are at or above goal lol
Never quit!
Maybe then finally some of the dead weight will finally be gone. There's one in my area that couldn't sell if their life depended on it.
I'm sure there is "dead weight" out there. There always is with large corporate sales forces. Maybe some of that "dead weight" is at the DM level...
Any more theories out there on a possible layoff or realignment?
My prediction, realignments to footprints that lost a rep to NSS. Potential DBM downsize. Hard to justify 6 reps per some districts.
I agree the NSS "roll out" was poorly executed and lack of specific direction is par for this company. If a new product(s) (in the primary care market) are not acquired asap, I can't imagine much of a future for us.
The CNS & GI specialist will ride off with the Oncology group and leave our sorry asses in the dust.
I agree the NSS "roll out" was poorly executed and lack of specific direction is par for this company. If a new product(s) (in the primary care market) are not acquired asap, I can't imagine much of a future for us.
The CNS & GI specialist will ride off with the Oncology group and leave our sorry asses in the dust.